Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0SNHGS
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
huPr1-vcMMAE
|
|||||
| Synonyms |
huPr1 vcMMAE; Anti-TMEFF2-auristatin E-conjugated(PDL BioPharma); huPr1vcMMAE
Click to Show/Hide
|
|||||
| Organization |
PDL BioPharma, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Prostate cancer [ICD11:2C82]
Investigative
|
|||||
| Antibody Name |
Anti-TMEFF2 mAb huPr1
|
Antibody Info | ||||
| Antigen Name |
Tomoregulin-2 (TMEFF2)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Mc-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
Vedotin
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.